These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3491879)

  • 1. Characterization of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, to neuromelanin.
    D'Amato RJ; Benham DF; Snyder SH
    J Neurochem; 1987 Feb; 48(2):653-8. PubMed ID: 3491879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin.
    D'Amato RJ; Lipman ZP; Snyder SH
    Science; 1986 Feb; 231(4741):987-9. PubMed ID: 3080808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromelanin: a role in MPTP-induced neurotoxicity.
    D'Amato RJ; Alexander GM; Schwartzman RJ; Kitt CA; Price DL; Snyder SH
    Life Sci; 1987 Feb; 40(8):705-12. PubMed ID: 2880274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra.
    Langston JW; Irwin I; Langston EB; Forno LS
    Neurosci Lett; 1984 Jul; 48(1):87-92. PubMed ID: 6332288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for neuromelanin involvement in MPTP-induced neurotoxicity.
    D'Amato RJ; Alexander GM; Schwartzman RJ; Kitt CA; Price DL; Snyder SH
    Nature; 1987 May 28-Jun 3; 327(6120):324-6. PubMed ID: 2884568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity?
    Irwin I; Langston JW
    Life Sci; 1985 Jan; 36(3):207-12. PubMed ID: 3871240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of the 1-methyl-4-phenyl-2,3-dihydropyridinium species with synthetic dopamine-melanin.
    Wu EY; Chiba K; Trevor AJ; Castagnoli N
    Life Sci; 1986 Nov; 39(18):1695-700. PubMed ID: 3490611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study.
    Herkenham M; Little MD; Bankiewicz K; Yang SC; Markey SP; Johannessen JN
    Neuroscience; 1991; 40(1):133-58. PubMed ID: 2052148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
    Perry TL; Yong VW; Jones K; Wall RA; Clavier RM; Foulks JG; Wright JM
    Neurosci Lett; 1985 Aug; 58(3):321-6. PubMed ID: 3876525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygen activation during the interaction between MPTP metabolites and synthetic neuromelanin--an ESR-spin trapping, optical, and oxidase electrode study.
    Korytowski W; Felix CC; Kalyanaraman B
    Biochem Biophys Res Commun; 1988 Jul; 154(2):781-8. PubMed ID: 2840906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.
    Hirsch E; Graybiel AM; Agid YA
    Nature; 1988 Jul; 334(6180):345-8. PubMed ID: 2899295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
    Bradbury AJ; Costall B; Domeney AM; Testa B; Jenner PG; Marsden CD; Naylor RJ
    Neurosci Lett; 1985 Oct; 61(1-2):121-6. PubMed ID: 2417166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+.
    Ransom BR; Kunis DM; Irwin I; Langston JW
    Neurosci Lett; 1987 Apr; 75(3):323-8. PubMed ID: 3495754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
    Chiba K; Trevor AJ; Castagnoli N
    Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on ultrastructure of nigral neuromelanin in Macaca fascicularis.
    Levi AC; DeMattei M; Ravazzani R; Corvetti G; Golden GT; Fariello RG
    Neurosci Lett; 1989 Jan; 96(3):271-6. PubMed ID: 2785665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromelanin synthesis in rat and human substantia nigra.
    Rabey JM; Hefti F
    J Neural Transm Park Dis Dement Sect; 1990; 2(1):1-14. PubMed ID: 2357268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pargyline prevents MPTP-induced parkinsonism in primates.
    Langston JW; Irwin I; Langston EB; Forno LS
    Science; 1984 Sep; 225(4669):1480-2. PubMed ID: 6332378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of the '4-5' double bond for neurotoxicity in primates of the pyridine derivative MPTP.
    Langston JW; Irwin I; Langston EB; Forno LS
    Neurosci Lett; 1984 Sep; 50(1-3):289-94. PubMed ID: 6333656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion in brain tissue by gas chromatography/mass spectrometry.
    Shih MC; Markey SP
    Biomed Environ Mass Spectrom; 1986 Feb; 13(2):85-9. PubMed ID: 2937483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
    Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ
    Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.